| Financial Year |
March 31 2023 |
| Monetary Funds |
1,138,109,543.86 |
| Held-for-trading Financial Assets |
122,794,117.99 |
| Notes Receivable |
4,249,322.83 |
| Accounts Receivable |
1,979,403,004.42 |
| Advances to Suppliers |
495,211,823.73 |
| Other Receivables |
253,434,414.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,652,342,882.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
679,098,972.19 |
| Total Current Assets |
10,937,893,385.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
116,850,007.17 |
| Long-term Equity Investment |
850,620,319.75 |
| Investment Properties |
56,015,652.55 |
| Fixed Assetes |
2,011,600,193.00 |
| Under-construction Projects |
1,158,185,912.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,661,350,763.54 |
| R&D expenses |
-- |
| Goodwill |
579,923,102.35 |
| Long-Term Deferred and Prepaid Expenses |
21,989,536.21 |
| Deferred Income Tax Assets |
91,599,535.39 |
| Other Non-Current Assets |
17,941,921.68 |
| Sub-Total of Non-Current Assets |
12,594,491,787.53 |
| Total Assets |
23,532,385,173.15 |
| Short-Term Loans |
4,534,247,699.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
464,641,082.70 |
| Accounts Payable |
2,527,307,634.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
65,581,251.23 |
| Taxes Payable |
385,756,713.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
111,915,232.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
405,966,437.50 |
| Other Current Liabilities |
12,472,968.95 |
| Sub-Total of Current Liabilities |
8,603,834,934.67 |
| Long-term Loans |
4,771,885,111.91 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
67,843,667.67 |
| Special Payable |
-- |
| Estimatied Liabilities |
165,773,143.59 |
| Deferred Income Tax Liabilities |
4,940,246.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,111,107,351.98 |
| Total Liabilities |
13,714,942,286.65 |
| Paid-In Capital(Or Share Stock) |
1,525,518,882.00 |
| Capital Surplus |
3,911,667,582.95 |
| Surplus Reserve |
248,584,239.81 |
| LESS:Treasury Stock |
22,025,094.00 |
| Undistributed Profits |
3,427,503,294.08 |
| Minority Stockholder's Interest |
721,475,444.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,095,967,442.00 |
| Owner's Equity（Stockholder's Equity） |
9,817,442,886.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,532,385,173.15 |
